This finding is consistent with our previous work, which showed durable and potent in vivo suppression of HIV-1 infection and prevention of CD4+ T cell depletion for 30 days in humanized mice treated with anti-HIV duoCAR T cell therapy (6). Here, CD4 is linked to HIV-1 infection.